IRMD

IRADIMED CORPORATION

$86.72

-0.25%
SectorHealthcareIndustryMedical DevicesCountryUnited States

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors in the United States and internationally.

Source: Yahoo Finance
AI summary

Price & performance

1M+3.7%
3M-4.7%
YTD-6.6%
1Y+3.5%
52-week range—
Beta0.81
Full chart and returns against a benchmark

Q-Score

89/ 100

Quality against peers; 50 is the peer median.

Growth74
Risk83
Performance70
Valuation39
Profitability92
Leverage96
Sentiment—
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$83.8M+14.4%
Net income$22.5M+16.9%
Net margin26.8%+0.6 pts
Historical fundamentals

Revenue exposure

16%of revenue from outside the US
United States84%
Non-US16%
Regions, segments, customers and suppliers

Valuation

IRMDIndustryP/E46.2429.61P/S12.413.49EV/EBITDA34.2718.38P/B10.423.39PEG3.503.50
Dividend yield1.46%
Every valuation metric

Earnings

Oct 30next report, before the open
EPS estimate$0.55
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate